*Facklamia hominis* is a catalase-negative facultative anaerobic and Gram-positive bacterium that was initially isolated from urine, vagina, blood and abscesses in humans [@bib1]. The bacteria was then recovered from placentas [@bib2], mitral valves [@bib3], [@bib4], and joints [@bib5]. Here we report the first human case of scapular abscess due to *F*. *hominis*, found in Marseille, France.

A 40-year-old woman was admitted to the emergency department at Casamance Hospital, Marseille, for persistent pain in an abscess located on the left scapula. For 15 years, the patient had an indurated mass on her left scapula after surgical evacuation of a worm. The first suppuration of this mass was reported 3 years ago. One week before hospitalization, she consulted her doctor for increasing pain and the formation of an abscess on her left scapula. Because the patient was apyretic, the doctor decided to treat her with pristinamycine. Upon admission on 29 January 2015, she was apyretic. She had no cervical adenopathy, and her white blood cell count was normal (4.18 × 10^9^/L). Surgical drainage of the infected abscess was performed. During surgery, a subcutaneous sample was recovered. After culture, *F. hominis* was repeatedly identified from several colonies tested by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF), with a score of 1.77. The bacterium was susceptible to ceftriaxone, gentamicin, erythromycin, rifampicin, doxycycline and vancomycin and resistant to clindamycin. At last contact, the patient was still being treated with pristinamycin.

*F. hominis* has been isolated exclusively from human samples ([Table 1](#tbl1){ref-type="table"}). Indeed, 67% (8/12) of all the *F. hominis* cases published worldwide were isolated from female human subjects ([Table 1](#tbl1){ref-type="table"}). The fact that this bacterial species has rarely been isolated from humans can be explained by the ineffectiveness of traditional microbiologic tests to accurately identify *F*. *hominis*. Previous studies have highlighted this problem, arguing that traditional microbiologic methods for microbial identification incorrectly identified *Facklamia* spp. strains as responsible for endocarditis, whereas 16S rRNA PCR finally identified *Enterococcus faecalis* [@bib4]. In the present study, the bacterial species was identified and confirmed several times using MALDI-TOF. Over the years, this strategy has considerably increased our capacity to detect rare bacterial species from clinical samples [@bib6]. [Table 1](#tbl1){ref-type="table"} summarizes the characteristics of the cases of *F. hominis* infection or carriage reported in the literature. In our case, and because the patient did not have any underlying conditions, we speculate that the infection was facilitated by repeated contact of the surgical site with contaminated surfaces such as hands. All together, our observations emphasize that *F. hominis* is an emerging pathogen that may be responsible for opportunistic infections in humans.
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Worldwide human infections with *Facklamia hominis*

  No. of patients (country)   Sex         Positive sample                             Identification method                            Antibiotic therapy provided                                                    Result             Reference
  --------------------------- ----------- ------------------------------------------- ------------------------------------------------ ------------------------------------------------------------------------------ ------------------ ------------
  6 (5 Sweden, 1 France)      4 F, 2 NA   1 urine, 3 vagina, 1 blood, 1 abscess       Characterization by API Rapid ID32 and API ZYM   NA                                                                             NA                 [@bib1]
  2 (United Kingdom)          2 F         Blood, placental tissue, gastric aspirate   NA                                               Co-amoxiclav, metronidazole, ampicillin, teicoplanin, gentamycin, cefotaxime   Discharged cured   [@bib2]
  1 (India)                   M           Blood                                       Vitek 2 system                                   Penicillin, gentamicin, ceftriaxone                                            Cured              [@bib3]
  1 (Spain)                   F           Sample from joint pseudo-capsule            Vitek 2 system 16S rRNA PCR                      Vancomycin gentamicin, ceftriaxone, amoxicillin                                Cured              [@bib5]
  1 (United Kingdom)          NA          Blood                                       NA                                               Amoxicillin + clavulanic acid, gentamicin, vancomycin                          Died               [@bib4]
  1 (France)                  F           Abscess                                     MALDI-TOF                                        Pristinamycine                                                                 Under treatment    This study

NA, data not available; MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
